alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,076–7,100 of 7,816 matching trials · page 284 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
NCT00937352
Bapineuzumab
Runs in: Austria; Canada; United States · 191 sites 		PHASE3
anti-amyloid-antibody		 TERMINATED 896 JANSSEN Alzheimer Immunotherapy Research & Development, LLC
INDUSTRY		 2013-12-20
SMART: Somatotrophics, Memory, and Aging Research Trial
NCT00257712
TH9507 human growth hormone releasing hormone (GHRH)
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 151 University of Washington
OTHER		 2013-12-19
Effect of Omega-3 Supplementation on Child Behavior Problems
NCT02016079
omega-3
Runs in: Mauritius · 1 site 		PHASE2|PHASE3
other		 COMPLETED 200 Joint Child Health Project, Mauritius
OTHER		 2013-12-19
Cognitive Behavioural Therapy for Persons With MCI or Mild Dementia
NCT02013518
Cognitive Behavioural Therapy
Runs in: Norway · 1 site 		NA
other		 UNKNOWN 200 Oslo University Hospital
OTHER		 2013-12-17
Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)
NCT00567060
Piracetam 		NA
other		 COMPLETED 676 UCB Pharma
INDUSTRY		 2013-12-16
Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
NCT01092546
[18F]Flutemetamol
Runs in: United States · 1 site 		PHASE3
other		 TERMINATED 12 GE Healthcare
INDUSTRY		 2013-12-13
Biotin Deficiency and Restless Legs Syndrome
NCT02011191
Biotin Supplementation; Sugar Pill 		NA
other		 COMPLETED 49 Heidi Moretti, MS, RD
OTHER		 2013-12-13
Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease
NCT01117818
active: AFFITOPE AD02; control: Placebo
Runs in: Austria; Croatia; Czechia; France; Germany; Slovakia · 31 sites 		PHASE2
other		 COMPLETED 335 Affiris AG
INDUSTRY		 2013-12-11
Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease
NCT01357629
Runs in: Austria · 2 sites 		NA
other		 TERMINATED 11 Affiris AG
INDUSTRY		 2013-12-11
VI-1121 for the Treatment Alzheimer's Disease
NCT01428362
VI-1121; Placebo
Runs in: United States · 11 sites 		PHASE2
other		 COMPLETED 61 VIVUS LLC
INDUSTRY		 2013-12-11
Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
NCT01908010
ABT-354; ABT-354; Placebo
Runs in: United States · 3 sites 		PHASE1
symptomatic-cholinergic		 COMPLETED 20 AbbVie
INDUSTRY		 2013-12-11
Blood-brain Barrier Permeability in Alzheimer's Disease
NCT01574456
Runs in: Netherlands · 2 sites 		NA
other		 COMPLETED 39 Maastricht University Medical Center
OTHER		 2013-12-10
Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation
NCT02005380
Text-based task; Graphic-based Task
Runs in: Jordan · 1 site 		NA
other		 COMPLETED 20 German-Jordanian University
OTHER		 2013-12-09
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
NCT00857649
Memantine; Placebo
Runs in: Canada · 23 sites 		PHASE3
symptomatic-cholinergic		 TERMINATED 369 H. Lundbeck A/S
INDUSTRY		 2013-12-05
Cognitive Impairment Following Cardiac Arrest and Target Temperature Management
NCT01946932
Temperature treatment
Runs in: Denmark; Italy; Netherlands; Sweden; United Kingdom · 20 sites 		NA
other		 COMPLETED 287 Region Skane
OTHER		 2013-12-05
Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels
NCT01165554
[18F] Flutemetamol
Runs in: United States · 1 site 		PHASE3
other		 COMPLETED 203 GE Healthcare
INDUSTRY		 2013-12-04
Prospective Research in Memory Clinics (PRIME)
NCT00297271
Current treatment practice of each participating physician
Runs in: Australia · 9 sites 		NA
other		 COMPLETED 970 Janssen-Cilag Pty Ltd
INDUSTRY		 2013-12-02
Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
NCT01438060
Aripiprazole (BMS-337039); Placebo 		PHASE3
other		 COMPLETED 232 Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY		 2013-12-02
Impact of a Memory Group for Older Adults Reporting Memory Difficulties
NCT01998711
Memory group
Runs in: Australia · 1 site 		NA
other		 COMPLETED 62 Bayside Health
OTHER_GOV		 2013-12-02
Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
NCT01261741
Memantine; Placebo
Runs in: Germany; United Kingdom · 14 sites 		PHASE2
symptomatic-cholinergic		 COMPLETED 299 Merz Pharmaceuticals GmbH
INDUSTRY		 2013-11-27
Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type
NCT01479855
Runs in: Norway · 1 site 		NA
other		 UNKNOWN 180 Oslo University Hospital
OTHER		 2013-11-27
Long-Term Lithium Treatment for Aggressive Conduct Disorder
NCT00000385
Lithium; Placebo
Runs in: United States · 1 site 		PHASE3
other		 COMPLETED 59 Drexel University
OTHER		 2013-11-26
A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease
NCT01249196
SK-PC-B70M
Runs in: South Korea · 1 site 		PHASE3
other		 COMPLETED 256 SK Chemicals Co., Ltd.
INDUSTRY		 2013-11-26
Montessori-Based Activities for Elderly Persons With Dementia
NCT00079651
Montessori-based dementia programming
Runs in: United States · 5 sites 		PHASE2|PHASE3
other		 COMPLETED 300 Menorah Park
OTHER		 2013-11-25
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
NCT00574132
Bapineuzumab 0.5 mg/kg; Placebo Control; Bapineuzumab 1.0 m/kg
Runs in: Austria; Canada; Germany; United States · 251 sites 		PHASE3
anti-amyloid-antibody		 COMPLETED 1,331 JANSSEN Alzheimer Immunotherapy Research & Development, LLC
INDUSTRY		 2013-11-25

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →